share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Kearney Terrence C

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Kearney Terrence C

福泰製藥 | 4:持股變動聲明-董事 Kearney Terrence C
美股SEC公告 ·  05/03 16:19

Moomoo AI 已提取核心訊息

Vertex Pharmaceuticals Inc. (VRTX) has reported a transaction involving Terrence C Kearney, a reporting person associated with the company. The transaction, which took place on 05/01/2024, did not specify Kearney's relationship to the issuer. Details regarding the nature of the shares, the number of shares transacted, the transaction price, and the resulting ownership stake after the transaction were not disclosed in the announcement.
Vertex Pharmaceuticals Inc. (VRTX) has reported a transaction involving Terrence C Kearney, a reporting person associated with the company. The transaction, which took place on 05/01/2024, did not specify Kearney's relationship to the issuer. Details regarding the nature of the shares, the number of shares transacted, the transaction price, and the resulting ownership stake after the transaction were not disclosed in the announcement.
Vertex Pharmicals Inc.(VRTX)報告了一筆涉及該公司相關舉報人特倫斯·科爾尼的交易。該交易於2024年1月5日進行,沒有具體說明科爾尼與發行人的關係。公告中沒有披露有關股票性質、交易股票數量、交易價格以及交易後由此產生的所有權的詳細信息。
Vertex Pharmicals Inc.(VRTX)報告了一筆涉及該公司相關舉報人特倫斯·科爾尼的交易。該交易於2024年1月5日進行,沒有具體說明科爾尼與發行人的關係。公告中沒有披露有關股票性質、交易股票數量、交易價格以及交易後由此產生的所有權的詳細信息。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息